J Cancer
2018; 9(6):1106-1112.
doi:10.7150/jca.23921 This issueCite
Research Paper
Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis
1. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China. 2. Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China. * These authors contributed equally to this work
✉ Corresponding author: Dr. Ying-Hong Shi, Address: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 FengLin Road, Shanghai, 200032, China. Tel.: (+86)-21-64041990-608621; fax: (+86)-21-64037181; E-mail: shi.yinghongsh.cnMore
Citation:
Tao CY, Liu WR, Jin L, Tang Z, Tian MX, Jiang XF, Wang H, Zhou PY, Fang Y, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. J Cancer 2018; 9(6):1106-1112. doi:10.7150/jca.23921. https://www.jcancer.org/v09p1106.htm
Aims: To compare the long-term prognosis of younger and elderly patients with combined hepatocellular-cholangiocarcinoma (CHC) who underwent curative resection between 1993 and 2014 at our center.
Methods: Two hundred and thirteen patients who underwent liver resection for CHC were enrolled in our study. The overall survival (OS) and disease-free survival (DFS) of elderly patients (age≥60, n=52) and younger patients (age<60, n=161) were compared by multivariate analysis and propensity score matching (PSM) analysis.
Results: Among the 213 CHC patients, the elderly patients had a higher rate of worse Child-Pugh grade (P=0.027), abnormal serum albumin (P<0.001) and lymphoid metastases (P=0.024). The proportion of HBV-positive CHC patients (74.6%, 159/213) was much higher than that observed in healthy cohorts. Younger patients had a higher rate of hepatitis B virus (HBV) infection compared to older patients (83.9% vs 46.2%, P<0.001). OS and DFS of the elderly and younger patients before and after propensity score matching were comparable.
Conclusion: Elderly and younger patients who underwent liver resection for CHC have comparable long-term OS and DFS.
Tao, C.Y., Liu, W.R., Jin, L., Tang, Z., Tian, M.X., Jiang, X.F., Wang, H., Zhou, P.Y., Fang, Y., Ding, Z.B., Peng, Y.F., Dai, Z., Qiu, S.J., Zhou, J., Fan, J., Shi, Y.H. (2018). Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. Journal of Cancer, 9(6), 1106-1112. https://doi.org/10.7150/jca.23921.
ACS
Tao, C.Y.; Liu, W.R.; Jin, L.; Tang, Z.; Tian, M.X.; Jiang, X.F.; Wang, H.; Zhou, P.Y.; Fang, Y.; Ding, Z.B.; Peng, Y.F.; Dai, Z.; Qiu, S.J.; Zhou, J.; Fan, J.; Shi, Y.H. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. J. Cancer 2018, 9 (6), 1106-1112. DOI: 10.7150/jca.23921.
NLM
Tao CY, Liu WR, Jin L, Tang Z, Tian MX, Jiang XF, Wang H, Zhou PY, Fang Y, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. J Cancer 2018; 9(6):1106-1112. doi:10.7150/jca.23921. https://www.jcancer.org/v09p1106.htm
CSE
Tao CY, Liu WR, Jin L, Tang Z, Tian MX, Jiang XF, Wang H, Zhou PY, Fang Y, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. 2018. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. J Cancer. 9(6):1106-1112.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.